277 related articles for article (PubMed ID: 208767)
1. Mammary tumor virus oncogenesis and tumor immunogenicity in three sublines of the C3H mouse.
Vaage J; Medina D
Cancer Res; 1978 Aug; 38(8):2443-7. PubMed ID: 208767
[TBL] [Abstract][Full Text] [Related]
2. Mammary tumorigenesis and tumor morphology in four C3H sublines with or without exogenous mammary tumor virus.
Vaage J; Smith GH; Asch BB; Teramoto Y
Cancer Res; 1986 Apr; 46(4 Pt 2):2096-100. PubMed ID: 2418961
[TBL] [Abstract][Full Text] [Related]
3. Correlation of in vitro and in vivo studies of antigens relevant to the control of murine breast cancer.
Stutman O
Cancer Res; 1976 Feb; 36(2 pt 2):739-47. PubMed ID: 175934
[TBL] [Abstract][Full Text] [Related]
4. Enhanced immune reactivity to hepatoma 22a cells in MTV-infected compared with MTV-free C3H mice.
Lavrovsky VA; Viksler VK
Immunology; 1981 Dec; 44(4):671-6. PubMed ID: 6274791
[TBL] [Abstract][Full Text] [Related]
5. [Increased immunologic reactivity against hepatoma 22A cells in MTV-infected C3H mice in comparison to MTV-free mice].
Lavrovskiĭ VA; Viksler VKh
Biull Eksp Biol Med; 1980 Oct; 90(10):467-9. PubMed ID: 6252986
[TBL] [Abstract][Full Text] [Related]
6. [Effect of early thymectomy on the growth of transplanted mammary gland tumors developing in mouse line C3Hf].
Videlets II; Gruntenko EV
Biull Eksp Biol Med; 1976 Jun; 81(6):721-3. PubMed ID: 182306
[TBL] [Abstract][Full Text] [Related]
7. Inherent changes in the in vivo growth characteristics of C3H/He mammary carcinomas.
Vaage J
Cancer Res; 1980 Oct; 40(10):3495-3501. PubMed ID: 7438036
[TBL] [Abstract][Full Text] [Related]
8. Changing transplantation characteristics with serial in vivo passage of C3H/He mammary carcinomas.
Vaage J
Cancer Res; 1978 Oct; 38(10):3264-8. PubMed ID: 688216
[TBL] [Abstract][Full Text] [Related]
9. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
10. Virus oncogenesis and tumor immunogenicity in the mouse mammary tumor system.
Vaage J; Medina D
Cancer Res; 1974 Jun; 34(6):1319-24. PubMed ID: 4363654
[No Abstract] [Full Text] [Related]
11. Natural immunity in the oncornavirus-infected mouse.
Blair PB
Cancer Res; 1976 Feb; 36(2 pt 2):734-8. PubMed ID: 175933
[TBL] [Abstract][Full Text] [Related]
12. Differences of milk-transmitted murine mammary tumor virus (MMTV) among mouse strains.
Sayama K; Takeda Y; Hashimoto H; Kaneko T; Matsuzawa A
In Vivo; 1999; 13(2):135-40. PubMed ID: 10363169
[TBL] [Abstract][Full Text] [Related]
13. Autogenous antibodies against the murine mammary tumor virus in strains of mice with low incidences of mammary tumors.
Michalides R; Wagenaar E; Nusse R
J Natl Cancer Inst; 1979 Apr; 62(4):935-41. PubMed ID: 219283
[TBL] [Abstract][Full Text] [Related]
14. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
[TBL] [Abstract][Full Text] [Related]
15. Immunology of spontaneous mammary carcinomas in mice: immunogenicity of mammary tumor virus-contaning tissues in mammary tumor virus-free C3H-2 hosts.
Lavrin DH
Cancer Res; 1970 Apr; 30(4):1156-62. PubMed ID: 4323351
[No Abstract] [Full Text] [Related]
16. In vitro detection of immune responses to MTV-induced mammary tumors: qualitative differences in response detected by time studies.
Blair PB; Lane MA
J Immunol; 1975 Jan; 114(1 Pt 1):17-23. PubMed ID: 163276
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of mammary tumor cultures from four mouse strains infected with mammary tumor virus.
Yagi MJ
Cancer Res; 1975 Feb; 35(2):370-3. PubMed ID: 162873
[TBL] [Abstract][Full Text] [Related]
18. Accelerated growth of mammary tumor cells in normal and athymic mice after treatment in vitro with dexamethasone.
Gillette RW; Wunderlich DA
Cancer Res; 1978 Oct; 38(10):3146-9. PubMed ID: 80260
[TBL] [Abstract][Full Text] [Related]
19. Relationship between tumor growth characteristics and preferential sites of growth.
Vaage J
J Natl Cancer Inst; 1984 May; 72(5):1199-203. PubMed ID: 6585595
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of immunity induced by neuraminidase-treated lymphosarcoma cells in C3H (MTV+) and C3H (MTV-) mice.
Bekesi JG; Roboz JP; Holland JF
Isr J Med Sci; 1976; 12(4-5):288-303. PubMed ID: 181351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
